Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02657486 · ClinicalTrials.gov registry record · NA
BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02657486: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02657486 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02657486, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to study the activity and effects of BGJ398 on bladder cancer tumors that are confined to the lining of the bladder.
Primary Outcome
with cystoscopy and cytology. A complete response will be defined as complete disappearance of the marker lesion at the week 7 evaluation, as determined by a negative cystoscopy and cytology.
Interventions
- DRUG BGJ398
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-01-06 |
| Est. Completion | 2026-02-04 |
| Phase | NA |
What the finished NCT02657486 record still lists
NCT02657486 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which BGJ398 is the first listed.
NCT02657486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02657486 about?
NCT02657486 is a clinical study titled "BGJ398 in Non-Muscle-Invasive Urothelial Carcinoma of the Bladder". The purpose of this study is to study the activity and effects of BGJ398 on bladder cancer tumors that are confined to the lining of the bladder.
What is the current status of trial NCT02657486?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2016-01-06. Estimated completion is 2026-02-04.
What interventions are being tested in trial NCT02657486?
The interventions under investigation include: BGJ398 (DRUG).
Who is sponsoring clinical trial NCT02657486?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02657486's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI